Skip to main content

Genetic Technologies Regains Compliance With Nasdaq Listing Rules

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies announced today that it has regained compliance with the Nasdaq's $1 minimum bid price requirement.

In July, Genetic Technologies said that it had been notified that its shares faced delisting from the exchange for trading below $1 for 30 consecutive business days. The company's stock has now regained listing compliance, having a minimum closing bid price per share of $1 or above for 10 consecutive business days.

During late morning trading, shares of Genetic Technologies were up nearly 12 percent at $1.3869.